• Integra LifeSciences reshuffled its commercial leadership following Mike McBreen’s appointment as executive vice president, chief commercial officer.
• Robert T. Davis Jr. named executive vice president, Tissue Reconstruction and Distributed Technologies, overseeing wound reconstruction, soft tissue, private label.
• Christopher Kilburn-Peterson promoted to corporate vice president, president of Tissue Reconstruction; previously senior vice president, general manager of Acclarent.
• Harvinder Singh appointed executive vice president, president of Specialty Surgery; previously led the international business.
• International regional leaders will now report directly to McBreen under the re-aligned commercial organization.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Integra LifeSciences Holdings Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606230800PRIMZONEFULLFEED9750608) on June 23, 2026, and is solely responsible for the information contained therein.